Grove Bank & Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-865
| Closed | -$103K | – | 490 |
|
|
2017
Q4 | $103K | Sell |
865
-379
| -30% | -$45.1K | 0.05% | 215 |
|
|
2017
Q3 | $175K | Sell |
1,244
-103
| -8% | -$14.5K | 0.09% | 170 |
|
|
2017
Q2 | $164K | Buy |
1,347
+890
| +195% | +$108K | 0.1% | 148 |
|
|
2017
Q1 | $55K | Buy |
457
+390
| +582% | +$46.9K | 0.05% | 203 |
|
|
2016
Q4 | $8K | Buy |
+67
| New | +$8K | 0.01% | 395 |
|